Clinical Trials Logo

Filter by:
NCT ID: NCT06386315 Recruiting - Clinical trials for Indolent B-Cell Non-Hodgkin Lymphoma

Reduced Dose Radiotherapy for the Treatment of Indolent Non-Hodgkin Lymphoma

Start date: May 15, 2024
Phase: Phase 2
Study type: Interventional

This phase II trial compares the safety, side effects and effectiveness of reduced dose radiation therapy to standard of care dose radiation in treating patients with indolent non-Hodgkin lymphoma. Radiation therapy uses high energy x-rays, particles, or radioactive seeds to kill cancer cells and shrink tumors. Standard of care radiation treatment for indolent non-Hodgkin lymphoma is usually delivered in 12 treatments. Studies have shown indolent lymphoma to be sensitive to radiation treatment, however, larger doses have higher rates of toxicities. A reduced radiation dose may be safe, tolerable and/or effective compared to standard of care radiation dose in treating patients with indolent non-Hodgkin lymphoma.

NCT ID: NCT06386289 Not yet recruiting - Clinical trials for Acute Ischemic Stroke

Safety, Performance of CEREGLIDE 92 Intermediate Catheter in Treatment of Acute Ischemic Stroke

SPLENDID
Start date: September 1, 2024
Phase: N/A
Study type: Interventional

The device is indicated for use in the revascularization of patients with acute ischemic stroke secondary to intracranial large vessel occlusive disease

NCT ID: NCT06386224 Recruiting - Clinical trials for Chronic Pancreatitis

Internet-Delivered Pain Self-Management for Persons With Acute Recurrent and Chronic Pancreatitis Pain

IMPACT-2
Start date: May 1, 2024
Phase: N/A
Study type: Interventional

Severe and disabling abdominal pain is common in individuals with chronic pancreatitis. Although pain is associated with reduced quality of life and high economic and societal costs, there are limited effective options for pain management in this population. This study proposes an evidence-based psychological intervention approach using an internet-delivered pain self-management program to minimize the impact of pain and improve quality of life. The ultimate goal is to maximize the public health impact of the intervention with successful implementation and dissemination to pancreas clinics and to the community.

NCT ID: NCT06386198 Recruiting - Pediatric ALL Clinical Trials

HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant Recipients

HEAL-Tx:ToC
Start date: March 3, 2024
Phase: N/A
Study type: Interventional

The Health Advocate for Liver Transplant (HEAL-Tx) Transition of Care Pilot is a nonrandomized, open-label intervention pilot of a health advocate intervention aimed to assess feasibility and acceptability of integrating a Health Advocate onto the transplant team to help adolescents transition their care to adult transplant teams. Across studies, health advocate roles vary, and can include coordinating medical care treatment, facilitating financial assistance (e.g., taxi vouchers), and connecting patients to community resources, which can improve self-management, mitigate social risks, and lead to better communication between the healthcare system and the family. In this pilot, the investigators will adapt this intervention for adolescent/young adult liver transplant patients and measure acceptability and feasibility according to RE-AIM.

NCT ID: NCT06386055 Not yet recruiting - Physical Inactivity Clinical Trials

Air Pollution and Physical Activity: A Randomized Controlled Trial

PARC
Start date: June 15, 2024
Phase: N/A
Study type: Interventional

This is a small pilot intervention trial in which we will collect preliminary data to demonstrate the feasibility of an intervention study.

NCT ID: NCT06386029 Not yet recruiting - Autism Clinical Trials

The Power Down Pilot Study: A Novel Bedtime Manipulation Protocol

Start date: May 2024
Phase: N/A
Study type: Interventional

The goal of this pilot intervention study is to examine the feasibility and acceptability of a novel bedtime manipulation protocol called "The Power Down" for autistic youth, ages 6-10. The main questions it aims to answer are: 1. Is the Power Down feasible for caregivers to do each night? 2. Do the families find the Power Down an acceptable intervention to address their child's difficulties settling down to fall asleep?

NCT ID: NCT06385938 Recruiting - Rickets Clinical Trials

Ultrasound Imaging and Quantitative Vibro-Acoustic Assessment of Rickets Under the Age of Ten

Start date: July 2024
Phase:
Study type: Observational

The goal of this study is to find out if the use of ultrasound pictures of bones can spot changes in the growth areas of children with rickets, a condition that affects how bones harden. Researchers want to see if these ultrasound pictures can help tell the difference between children who have rickets and those who don't.

NCT ID: NCT06385925 Recruiting - Malignant Neoplasm Clinical Trials

A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

Start date: April 29, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

The study is a first-in-human (FIH), open-label, multi-center phase 1/2 study of TSN1611 in subjects with KRAS G12D mutant advanced solid tumors. This study will consist of a phase 1 dose escalation part and phase 2 dose expansion part.

NCT ID: NCT06385886 Recruiting - Sickle Cell Disease Clinical Trials

Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease

RECIPE
Start date: June 8, 2023
Phase:
Study type: Observational

The goal of this observational study is to help us understand more about the best ways to help individuals living with Sickle Cell Disease (SCD) get the best care. The main question it aims to answer is: How to find individuals unaffiliated from SCD specialist care use three distinct pathways? Once unaffiliated individuals are found using the pathways, Investigators will employ linkage coordinators (trained staff) to engage these patients in care. Participants will be asked to fill out an assessment survey which will cover areas such as previous and current treatment, clinic and hospital experience, pain, and quality of life. Participants will also be given the option of participation in a 1-hour long interview how they feel about treatment for sickle cell disease including clinic experience, pain, and quality of life?

NCT ID: NCT06385795 Recruiting - Menopause Clinical Trials

A Study of NOE-115 in Women With Vasomotor Symptoms Due to Menopause

Start date: April 22, 2024
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine the safety, tolerability, and preliminary effectiveness of NOE-115 on moderate to severe vasomotor symptoms (hot flashes) due to menopause in women.